Filtered By:
Infectious Disease: Coronavirus
Drug: Coumadin

This page shows you your search results in order of date.

Order by Relevance | Date

Total 3 results found since Jan 2013.

Ischemic stroke in the setting of supratherapeutic International Normalized Ratio following coronavirus disease 2019 infection: a case report
ConclusionsThis case report highlights the potential for thromboembolic events, including stroke, in patients with COVID-19 infection, even when receiving therapeutic anticoagulation therapy. Healthcare providers should be vigilant for signs of thrombosis in COVID-19 patients, particularly those with pre-existing risk factors. Further research is necessary to understand the pathophysiology and optimal management of thrombotic complications in COVID-19 patients.
Source: Journal of Medical Case Reports - May 31, 2023 Category: General Medicine Source Type: research

Splenic Infarction with Aortic Thrombosis in COVID-19
Am J Med Sci. 2021 Jun 20:S0002-9629(21)00238-X. doi: 10.1016/j.amjms.2021.06.007. Online ahead of print.ABSTRACTCoronavirus disease 2019 (COVID-19) has been associated with an increased risk of venous and arterial thrombotic disease. Although pulmonary embolism has been the most common thrombotic complication, there have been recent reports of COVID-19-associated large-vessel ischemic stroke, acute upper- and lower-limb ischemia, as well as infarctions of the abdominal viscera, including renal, splenic, and small bowel infarctions. Here, we describe a case of splenic infarction (SI) associated with aortic thrombosis, whic...
Source: The American Journal of the Medical Sciences - June 23, 2021 Category: General Medicine Authors: Jaques Sztajnbok Lucas Mendes Cunha de Resende Brasil Luis Arancibia Romero Ana Freitas Ribeiro Jose Ernesto Vidal Claudia Figueiredo-Melo Ceila Maria Sant'Ana Malaque Source Type: research

Stroke Care during the COVID-19 Pandemic: International Expert Panel Review
This study, prepared by a large international panel of stroke experts, assesses the rapidly growing research and personal experience with COVID-19 stroke and offers recommendations for stroke management in this challenging new setting: modifications needed for prehospital emergency rescue and hyperacute care; inpatient intensive or stroke units; posthospitalization rehabilitation; follow-up including at-risk family and community; and multispecialty departmental developments in the allied professions.Summary: The severe acute respiratory syndrome coronavirus 2 uses spike proteins binding to tissue angiotensin-converting enz...
Source: Cerebrovascular Diseases - March 23, 2021 Category: Neurology Source Type: research